In Vitro and In Vivo Evaluation of Nanoparticles Prepared by Nano Spray Drying for Stomach Mucoadhesive Drug Delivery

REFERENCES

• Bloom, D.E.; Cafiero, E.T.; Jané-Llopis, E.; Abrahams-Gessel, S.; Bloom, L.R.; Fathima, S.; Feigl, A.B.; Gaziano, T.; Mowafi, M.; Pandya, A.; Prettner, K.; Rosenberg, L.; Seligman, B.; Stein, A.Z.; Weinstein, C. The Global Economic Burden of Noncommunicable Diseases; World Economic Forum: Geneva, Switzerland, 2011.
   Google Scholar
• Alhowaish, A.K. Economic costs of diabetes in Saudi Arabia. Journal of Family and Community Medicine 2013, 20, 1–7.
   PubMedGoogle Scholar
• Ali, H.S. Effectiveness of the use of Cutimed Sorbact versus standard dressing by nurses in diabetic foot ulcer. Life Science Journal 2013, 10, 1083–1091.
   Google Scholar
• Midhet, F.M.; Al-Mohaimeed, A. Impact of indoor education on the lifestyles of patients with chronic disease in a secondary hospital in Qassim, Kingdom of Saudi Arabia. Journal of Taibah University Medical Sciences 2013, 8, 44–49.
   Google Scholar
• Steyn, N.P.; Mann, J.; Bennett, P.H.;. Diet, nutrition and the prevention of type 2 diabetes. Public Health Nutrition 2004, 7, 147–165.
   PubMed Web of Science ®Google Scholar
• Chaluvaraju, K.; Mane, K.; Niranjan, M.; Zaranappa, T.; Manjuthej, T. Review of insulin and its analogues in diabetes mellitus. Journal of Basic and Clinical Pharmacy 2012, 3, 283–293.
   PubMedGoogle Scholar
• Harsha, S.; Aldhubiab, B.E.; Ibrahim, A.A.; Attimard, M.; Nair, A.B. Carbopol 934-P loaded with vildagliptin for diabetic delivery: In vitro and in vivo evaluation of nanoparticles. Current Nanosciences 2013, 9, 642–647.
   Web of Science ®Google Scholar
• Tahrani, A.; Piya, M.; Barnett, A. Drug evaluation: Vildagliptin–metformin single-tablet combination. Advances in Therapy 2009, 26, 138–154.
   PubMed Web of Science ®Google Scholar
• Halimi, S.; Schweizer, A.; Minic, B.; Foley, J.; Dejager, S. Combination treatment in the management of type 2 diabetes: Focus on vildagliptin and metformin as a single tablet. Vascular Health and Risk Management 2008, 4(3), 481–492.
   PubMedGoogle Scholar
• Tzoulaki, I.; Molokhia, M.; Curcin, V.; Little, M.P.; Millett, C.J.; Ng, A.; Hughes, R.I.; Khunti, K.; Wilkins, M.R.; Majeed, A.; Elliott, P. Risk of cardiovascular disease and all cause mortality among patients with type 2 diabetes prescribed oral antidiabetes drugs: Retrospective cohort study using UK general practice research database. British Medical Journal 2009, 339, b4731.
   PubMed Web of Science ®Google Scholar
• Derosa, G.; Maffioli, P. Patient considerations and clinical utility of a fixed dose combination of saxagliptin/metformin in the treatment of type 2 diabetes. Diabetes, Metabolic Syndrome and Obesity 2011, 4, 263–271.
   PubMedGoogle Scholar
• Derosa, G.; Ragonesi, P.D.; Carbone, A.;. Evaluation of the positive effects on insulin-resistance and β-cell measurements of vildagliptin in addition to metformin in type 2 diabetic patients. Pharmacological Research 2013, 73, 20–26.
   PubMed Web of Science ®Google Scholar
• Derosa, G.; Maffioli, P. Dipeptidyl peptidase-4 inhibitors: 3 Years of experience. Diabetes Technology & Therapeutics 2012, 14, 350–364.
   PubMed Web of Science ®Google Scholar
• Fowler, M.J. Diabetes treatment, Part 2: Oral agents for glycemic management. Clinical Diabetes 2007, 25, 131–134.
   Google Scholar
• Ito, M.; Abe, M.; Okada, K.;. The dipeptidyl peptidase-4 (DPP-4) inhibitor vildagliptin improves glycemic control in type 2 diabetic patients undergoing hemodialysis. Endocrine Journal 2011, 58, 979–987.
   PubMed Web of Science ®Google Scholar
• White, J.R. Dipeptidyl peptidase-IV inhibitors: Pharmacological profile and clinical use. Clinical Diabetes 2008, 26, 53–57.
   Google Scholar
• DeFronzo, R.A.; Eldor, R.; Abdul-Ghani, M. Pathophysiologic approach to therapy in patients with newly diagnosed type 2 diabetes. Diabetes Care 2013, 36, S127–S138.
   PubMed Web of Science ®Google Scholar
• Schweizer, A.; Foley, J.E.; Kothny, W.; Ahren, B. Clinical evidence and mechanistic basis for vildagliptin's effect in combination with insulin. Vascular Health and Risk Management 2013, 9, 57–64.
   PubMedGoogle Scholar
• Green, J.; Feinglos, M. New combination treatments in the management of diabetes: Focus on sitagliptin–metformin. Vascular Health and Risk Management 2008, 4, 743–751.
   PubMedGoogle Scholar
• He, Y.L.; Paladini, S.; Sabia, H.;. Bioequivalence of vildagliptin/metformin fixed-dose combination tablets and a free combination of vildagliptin and metformin in healthy subjects. International Journal of Clinical Pharmacology and Therapeutics 2008, 46, 259–267.
   PubMed Web of Science ®Google Scholar
• Scheen, A.J. Clinical pharmacokinetics of metformin. Clinical Pharmacokinetics 1996, 30, 359–371.
   PubMed Web of Science ®Google Scholar
• Harsha, S.; Attimard, M.; Khan, T.A.;. Design and formulation of mucoadhesive microspheres of sitagliptin. Journal of Microencapsulation 2013, 30, 257–264.
   PubMed Web of Science ®Google Scholar
• Swami, A.; Shi, J.; Gadde, S.; Votruba, A.; Kolishetti, N.; Farokhzad, O. Nanoparticles for targeted and temporally controlled drug delivery. In Multifunctional Nanoparticles for Drug Delivery Applications; Svenson, S.; Prud'homme, R.K. Eds.; Springer: New York, 2012; 9–29.
   Google Scholar
• Farokhzad, O.C.; Langer, R. Impact of nanotechnology on drug delivery. ACS Nano 2009, 3, 16–20.
   PubMed Web of Science ®Google Scholar
• Sambathkumar, R.; Venkateswaramurthy, N.; Vijayabaskaran, M.; Perumal, P. Formulation of clarithromycin loaded mucoadhesive microspheres by emulsification–internal gelation technique for anti–Helicobacter pylori therapy. International Journal of Pharmacy and Pharmaceutical Sciences 2011, 3, 173–177.
   Google Scholar
• Moogooee, M.; Ramezanzadeh, H.; Jasoori, S.; Omidi, Y.; Davaran, S. Synthesis and in vitro studies of cross-linked hydrogel nanoparticles containing amoxicillin. Journal of Pharmaceutical Sciences 2011, 100, 1057–1066.
   PubMed Web of Science ®Google Scholar
• Zhang, W.F.; Chen, X.G.; Li, P.W.; Liu, C.S.; He, Q.Z. Preparation and characterization of carboxymethyl chitosan and beta-cyclodextrin microspheres by spray drying. Drying Technology 2008, 26, 108–115.
   Web of Science ®Google Scholar
• Narkar, M.; Sher, P.; Pawar, A. Stomach-specific controlled release gellan beads of acid-soluble drug prepared by ionotropic gelation method. AAPS PharmSciTech 2010, 11, 267–277.
   PubMed Web of Science ®Google Scholar
• Awasthi, R.; Kulkarni, G.T.; Pawar, V.K.; Garg, G. Optimization studies on gastroretentive floating system using response surface methodology. AAPS PharmSciTech 2011, 1–9.
   Google Scholar
• Harsha, S. Dual drug delivery system for targeting H. pylori in the stomach: Preparation and in vitro characterization of amoxicillin-loaded Carbopol® nanospheres. International Journal of Nanomedicine 2012, 7, 4787–4796.
   PubMed Web of Science ®Google Scholar
• Harsha, S. Pharmaceutical suspension containing both immediate/sustained-release amoxicillin-loaded gelatin nanoparticles: Preparation and in vitro characterization. Drug Design, Development and Therapy 2013, 7, 1027–1033.
   PubMed Web of Science ®Google Scholar
• Hosseinzadeh, H.; Atyabi, F.; Dinarvand, R.; Ostad, S.N. Chitosan–pluronic nanoparticles as oral delivery of anticancer gemcitabine: Preparation and in vitro study. International Journal of Nanomedicine 2012, 7, 1851–1863.
   PubMed Web of Science ®Google Scholar
• de Villiers, M.M.; Aramwit, P.; Kwon, G.S. Nanotechnology in Drug Delivery; Springer: New York, 2008.
   Google Scholar
• Rao, J.P.; Geckeler, K.E. Polymer nanoparticles: Preparation techniques and size-control parameters. Progress in Polymer Science 2011, 36, 887–913.
   Web of Science ®Google Scholar
• Lee, S.H.; Heng, D.; Ng, W.K.; Chan, H.K.; Tan, R.B. Nano spray drying: a novel method for preparing protein nanoparticles for protein therapy. International Journal of Pharmacy 2011, 403, 192–200.
   PubMed Web of Science ®Google Scholar
• Arpagaus, C. A novel laboratory-scale spray dryer to produce nanoparticles. Drying Technology 2012, 30, 1113–1121.
   Web of Science ®Google Scholar
• Littringer, E.M.; Zellnitz, S.; Hammernik, K.; Adamer, V.; Friedl, H.; Urbanetz, N.A. Spray drying of aqueous salbutamol sulfate solutions using the Nano Spray Dryer B-90—The impact of process parameters on particle size. Drying Technology 2013, 31, 1346–1353.
   Web of Science ®Google Scholar
• Yeo, Y.; Baek, N.; Park, K. Microencapsulation methods for delivery of protein drugs. Biotechnology and Bioprocess Engineering 2001, 6, 213–230.
   Google Scholar
• Ré, M.-I. Formulating drug delivery systems by spray drying. Drying Technology 2006, 24, 433–446.
   Web of Science ®Google Scholar
• Gad, S.C. Pharmaceutical Manufacturing Handbook: Production and Processes; Wiley: New York, 2008.
   Google Scholar
• Baba, K.; Nishida, K. Steroid nanocrystals prepared using the Nano Spray Dryer B-90. Pharmaceutics 2013, 5, 107–114.
   PubMedGoogle Scholar
• Baba, K.; Nishida, K. Calpain inhibitor nanocrystals prepared using Nano Spray Dryer B-90. Nanoscale Research Letters 2012, 7, 436.
   PubMed Web of Science ®Google Scholar
• Li, X.; Anton, N.; Arpagaus, C.; Belleteix, F.; Vandamme, T.F. Nanoparticles by spray drying using innovative new technology: The Büchi Nano Spray Dryer B-90. Journal of Controlled Release 2010, 147, 304–310.
   PubMed Web of Science ®Google Scholar
• Mohanraj, V.; Chen, Y. Nanoparticles—A review. Tropical Journal of Pharmaceutical Research 2007, 5, 561–573.
   Google Scholar
• Smola, M.; Vandamme, T.; Sokolowski, A. Nanocarriers as pulmonary drug delivery systems to treat and to diagnose respiratory and non respiratory diseases. International Journal of Nanomedicine 2008, 3, 1–19.
   PubMed Web of Science ®Google Scholar
• Harsha, S.; Attimarad, M.; Khan, T.;. Design and formulation of mucoadhesive microspheres of sitagliptin. Journal of Microencapsulation 2013, 30(3), 257–264.
   PubMed Web of Science ®Google Scholar
• Harsha, N.S.; Aldhubiab, E.B.; Abdulrahman Alhaider, I.; Attimarad, M.; Nair, A. Carbopol 934-P loaded with vildagliptin for diabetic delivery: In vitro and in vivo evaluation of nanoparticles. Current Nanoscience 2013, 9, 642–647.
   Web of Science ®Google Scholar
• Singh, K.P.; Chhabra, G.; Sharma, V.; Pathak, K. Thermosensitive periodontal sol of ciprofloxacin hydrochloride and serratiopeptidase: Pharmaceutical and mechanical analysis. International Journal of Pharmaceutical Investigation 2014, 4, 5–14.
   PubMedGoogle Scholar
• Dai, H.; Gao, X.; Liu, E.;. Synthesis and characterization of graphitic carbon nitride sub-microspheres using microwave method under mild condition. Diamond and Related Materials 2013, 38, 109–117.
   Web of Science ®Google Scholar
• Shah, R.; Tawakkul, M.; Khan, M. Comparative evaluation of flow for pharmaceutical powders and granules. AAPS PharmSciTech 2008, 9, 250–258.
   PubMed Web of Science ®Google Scholar
• Saikia, C.; Hussain, A.; Ramteke, A.; Sharma, H.K.; Maji, T.K. Carboxymethyl starch–chitosan-coated iron oxide magnetic nanoparticles for controlled delivery of isoniazid. Journal of Microencapsulation (in press).
   Google Scholar
• Mahesh, A.; Harsha, S.; Aldhubaib, B.E.; Ahmed, A.-N. Development of a rapid RP-HPLC method for simultaneous determination of metformin and vildagliptin in formulation and human plasma. Journal of Young Pharmacists 2014, 6, 40–46.
   Google Scholar
• Devrim, B.; Bozkir, A.; Canefe, K. Formulation and evaluation of reconstitutable suspensions containing ibuprofen-loaded Eudragit microspheres. Acta Poloniae Pharmaceutica 2011, 68, 593–599.
   PubMed Web of Science ®Google Scholar
• Gomez-Estaca, J.; Balaguer, M.P.; Gavara, R.; Hernandez-Munoz, P. Formation of zein nanoparticles by electrohydrodynamic atomization: Effect of the main processing variables and suitability for encapsulating the food coloring and active ingredient curcumin. Food Hydrocolloids 2012, 28, 82–91.
   Web of Science ®Google Scholar
• Ferrari, M.; Lee, A.P.; Lee, J. BioMEMS and Biomedical Nanotechnology: Vol. I. Biological and Biomedical Nanotechnology; Springer: New York, 2007.
   Google Scholar
• Harsha, N.S.; Rani, R.H.S. Drug targeting to lungs by way of microspheres. Archives of Pharmacal Research 2006, 29, 598–604.
   PubMed Web of Science ®Google Scholar
• Li, X.; Anton, N.; Arpagaus, C.; Belleteix, F.; Vandamme, T.F. Nanoparticles by spray drying using innovative new technology: The Buchi Nano Spray Dryer B-90. Journal of Controlled Release 2014, 37(3), 352–360.
   Google Scholar
• Harsha, S.; Al-Khars, M.; Al-Hassan, M.;. Pharmacokinetics and tissue distribution of spray-dried carboplatin microspheres: Lung targeting via intravenous route. Archives of Pharmacal Research 2013, 1–9.
   PubMed Web of Science ®Google Scholar
• Sibghatullah, S.; Mansour, A.T.; Otaibi, G.A.; Hazoom, M.A.K.A.; Harsha, S. Analysis and evaluation of prescriptions in Al-Ahsa (Saudi Arabia). Ars Pharmaceutica 2012, 53, 28–31.
   Google Scholar
• Harsha, S.; Attimard, M.; Khan, T.A.;. Design and formulation of mucoadhesive microspheres of sitagliptin. Journal of Microencapsulation 2013, 30, 257–264.
   PubMed Web of Science ®Google Scholar
• Harsha, S.; Chandramouli, R.; Rani, S. Ofloxacin targeting to lungs by way of microspheres. International Journal of Pharmaceutics 2009, 380, 127–132.
   PubMed Web of Science ®Google Scholar
• Mohammed, A.; Shabir, A.; Alhusban, F.; Perrie, Y. Effects of ball-milling on PLGA polymer and its implication on lansoprazole-loaded nanoparticles. Journal of Basic and Clinical Pharmacy 2011, 2(2), 71–82.
   PubMedGoogle Scholar
• Nicholas, A.P. Water diffusion and sorption in amorphous macromolecular systems and foods. Journal of Food Engineering 1994, 22, 189–210.
   Web of Science ®Google Scholar
• Wen, H.; Park, K. Oral Controlled Release Formulation Design and Drug Delivery: Theory to Practice; Wiley: New York, 2011.
   Google Scholar
• Patel, J.; Patel, D.; Raval, J. Formulation and evaluation of propranolol hydrochloride-loaded Carbopol-934P/ethyl cellulose mucoadhesive microspheres. Iranian Journal of Pharmaceutical Research 2010, 9, 221–232.
   PubMed Web of Science ®Google Scholar
• Smart, J.D. Some formulation factors influencing the rate of drug release from bioadhesive matrices. Drug Development and Industrial Pharmacy 1992, 18, 222–232.
   Web of Science ®Google Scholar
• Dumitriu, S. Polymeric Biomaterials, Revised and Expanded; Taylor & Francis: Boca Raton, FL, 2001.
   Google Scholar
• Ensign, L.M.; Cone, R.; Hanes, J. Oral drug delivery with polymeric nanoparticles: The gastrointestinal mucus barriers. Advanced Drug Delivery Reviews 2012, 64, 557–570.
   PubMed Web of Science ®Google Scholar
• Harsha, N.S.; Rani, R.H. Drug targeting to lungs by way of microspheres. Archives of Pharmacal Research 2006, 29, 598–604.
   PubMed Web of Science ®Google Scholar
• De, S.; Robinson, D.H. Particle size and temperature effect on the physical stability of PLGA nanospheres and microspheres containing Bodipy. AAPS PharmSciTech 2004, 5, e53.
   PubMed Web of Science ®Google Scholar